. Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemi

TANRIKULU ŞİMŞEK E., EŞKAZAN A. E., CENGİZ M., AR C., EKİZOĞLU ERATAK S., SALİHOĞLU A., ...More

57th ASH Annual Meeting and Exposition, Orlando, United States Of America, 5 - 08 December 2015, (Full Text)

  • Publication Type: Conference Paper / Full Text
  • City: Orlando
  • Country: United States Of America
  • Istanbul University Affiliated: Yes